MedPath

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

Not Applicable
Recruiting
Conditions
Substance Use
HIV Infections
Interventions
Behavioral: Couples Health Project
Registration Number
NCT06307977
Lead Sponsor
Hunter College of City University of New York
Brief Summary

This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI or standard couples HIV testing and counseling (CHTC).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
360
Inclusion Criteria
  • Have a main partner who is another cisgender male and have been in a relationship for 3 month or longer
  • Index participant must be between 18 and 34; Main partner can be any age 18 and older
  • One participant must be HIV negative (as confirmed by rapid test)
  • One participant must have used at least 1 drug in the past 30 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB, amyl nitrite)
  • Index participant must have engaged in TRB in the past 30 days- Defined as CAS with a casual partner, or a serodiscordant or non-monogamous main partner
  • Live in the United States
  • Speak and read English

Exclusion Criteria

  • Any signs of serious mental illness or cognitive deficit
  • Current suicidal/homicidal ideations
  • History of IPV with their main partner and safety concerns in the current relationship.
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Behavioral: Couples Health ProjectCouples Health ProjectA three-session intervention for couples addressing couples communication skills, substance use, sexual agreements. The intervention also includes couples HIV testing and counseling in the final session.
Primary Outcome Measures
NameTimeMethod
Urine assay for drug use9 Months

Positive urine screen for drug use assessed bi-annually

Drug use Frequency9 Months

Number of reported days of illicit drug use (amphetamines, cocaine/crack, GHB, ketamine or ecstasy) reported on quarterly timeline follow-back assessments

CAS with casual partners9 Months

Number of total anal sex acts (insertive and receptive) with casual partners reported on quarterly timeline follow-back assessments in the absence of adequate PrEP coverage

Secondary Outcome Measures
NameTimeMethod
Binge Drinking9 Months

Number of days on which 5 or more drinks containing alcohol were reported on the quarterly timeline follow-back interview

PrEP Uptake9 months

self-reported receipt of a PrEP-prescription

Bacterial sexually transmitted infections9 Months

Any chlamydia or gonorrhea diagnosis

Trial Locations

Locations (3)

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Wayne State University

🇺🇸

Detroit, Michigan, United States

Hunter College

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath